药物开发 药物开发
Praveen Nekkar Rao1, Ahmed Abdallah Hefny1, Rahul C Karuturi1
1University of Waterloo, Waterloo, ON, Canada.
Alzheimer's & dementia : the journal of the Alzheimer's Association
|December 26, 2025
概括
新型基于的小分子,N-基索酶,有效抑制粉样β聚合,并具有抗氧化特性. 这些发现表明它们可能成为新的阿尔茨海默病治疗方法.
科学领域:
- 药用化学 医学化学
- 神经科学是一个神经科学.
- 药物发现 药物发现 药物发现
背景情况:
- 阿尔茨海默氏症 (AD) 是导致痴呆的主要原因,全球有超过5500万人受到影响.
- 由于缺乏有效的阿尔茨海默病治疗方法,因此需要新的治疗策略.
- 准粉样β (Aβ) 聚合是一种对阿尔茨海默病有前途的治疗方法.
研究的目的:
- 设计和合成基于的新型小分子,N-基索酶.
- 评估这些化合物在抑制Aβ聚合和神经毒性的潜力.
- 评估它们的抗氧化活性和细胞毒性,用于潜在的阿尔茨海默病治疗.
主要方法:
- 通过优化化学协议合成N-基色氨酸库.
- 在体外对抗Aβ40聚合的评估,使用蒂奥夫拉-T光和电子显微镜.
- 在小鼠海马神经元细胞中评估抗氧化活性和细胞毒性.
主要成果:
- 成功合成N-基色酶,产量在23-89%之间.
- 这些化合物显示出显著的Aβ40聚合抑制 (26-85%) 和抗氧化活性 (23-80.5%).
- 在小鼠海马HT22神经元细胞中没有观察到细胞毒性.
结论:
- 基于的新型N-基索酶在减少Aβ40聚合方面表现有前途.
- 这些化合物具有抗氧化特性,表明它们有可能成为阿尔茨海默氏症疾病的疾病修饰剂.
- 对这些小分子的进一步研究可能会为AD带来新的治疗选择.
更多相关视频
08:04In Vitro Three-Dimensional Sprouting Assay of Angiogenesis Using Mouse Embryonic Stem Cells for Vascular Disease Modeling and Drug Testing
Published on: May 11, 2021
3.3K
05:45Developmental Toxicity Assay Based on Real-Time Monitoring of Fibroblast Growth Factor Signal Disruption in Human Induced Pluripotent Stem Cells
Published on: October 10, 2025
451
相关概念视频
Preclinical Development: Overview
5.7K
Preclinical development consists of a series of tests that ensure the safety and efficacy of a new therapeutic compound before it is tested in humans. There are four main phases to this process. First, safety pharmacology tests are conducted to ensure the drug does not produce any acutely harmful effects. These tests examine parameters such as bronchoconstriction, cardiac dysrhythmias, blood pressure changes, and ataxia. Next, preliminary toxicological testing is performed to determine the...
5.7K
Clinical Trials: Overview
4.5K
Clinical development focuses on how the drug will interact with the human body and encompasses four key phases of clinical trials, each serving a specific purpose in assessing the safety and effectiveness of new drugs. These phases overlap and build upon one another. Phase I involves a small group of healthy volunteers (typically 20-80 individuals) or, in cases where significant toxicity is expected, patients with the targeted disease, such as cancer or AIDS. The volunteers are tested for...
4.5K
Drug Discovery: Overview
10.9K
Drug discovery is a multifaceted process involving extensive screening, testing, and optimization of lead compounds to identify potential new drugs for therapeutic use. It combines several approaches, including screening large numbers of natural products, chemical modification of known active molecules, identification of new drug targets, and rational design based on biological mechanisms and drug-receptor structure. These approaches are carried out in both academic research laboratories and...
10.9K
Drug Administration and Therapy Phases: Overview
1.1K
Drugs, the chemical agents used in diagnosing, treating, or preventing diseases, undergo a four-phase process of development: pharmaceutic, pharmacokinetics, pharmacodynamics, and therapeutic.
The pharmaceutical phase focuses on leveraging the physicochemical properties of the drug to design and manufacture an effective product. Variants include orally administered tablets or capsules, topical creams or ointments, and parenteral-delivery solutions or emulsions.
The pharmacokinetic phase...
The pharmaceutical phase focuses on leveraging the physicochemical properties of the drug to design and manufacture an effective product. Variants include orally administered tablets or capsules, topical creams or ointments, and parenteral-delivery solutions or emulsions.
The pharmacokinetic phase...
1.1K
In Vitro Drug Release Testing: Overview, Development and Validation
279
In vitro dissolution and drug release tests assess how quickly and how much of a drug is released from its dosage form into an aqueous medium under standardized laboratory conditions. These tests are essential tools in pharmaceutical development and quality assurance, offering insight into the drug's performance before clinical use.During formulation development, dissolution testing identifies incomplete or inconsistent drug release issues. It also supports decisions on selecting the optimal...
279
Drug Regulation
2.7K
Drug regulation encompasses the management of drug usage by evaluating its safety and efficacy through assessments conducted by regulatory authorities. Regrettably, the history of drug regulation is marred by several catastrophic events. One such incident is the Elixir Sulfanilamide tragedy, in which the toxic compound diethyl glycol was included in a sweet-tasting medication, leading to numerous fatalities. This event prompted the enactment of the Food, Drug, and Cosmetic Act in 1938. Under...
2.7K
